fashion -WSS

fashion

author：fashion 2025-09-06 04:17:17 - browse：4

From left, STAT's Allison DeAngelis, ALS advocate Cathy Collet, Yale's Gregg Gonsalves, Sick Cells' Ashley Valentine, and Canary Advisors' Jennifer McNary at a panel at the 2024 STAT Breakthrough Summit East. STAT

NEW YORK — Over 30 years ago, Gregg Gonsalves and other AIDS activists persuaded Congress to create the accelerated approval pathway, allowing regulators to speed access to drugs for thousands of dying patients.

These days, though, Gonsalves sounds uneasy — if not mournful — of the world he helped build.

“We’re approving drugs faster and faster — [the FDA is] one of the fastest regulatory agencies in the world — we know less and less about them, and we pay more and more for them,” said Gonsalves, now a professor at Yale, at STAT Breakthrough Summit East on Thursday. “So in that way, the system is not working. We basically put access out there as this talisman of hope, but we don’t compel the companies that give us answers about what these drugs do in our bodies.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Roivant's CEO is a star, but biotech's black hole persists

focus

entertainment

WSS

Study on Amgen’s bispecific immunotherapy produces positive data

A new House health package & hospitals’ new site

How to protect patients from sexual assault

How to fix cancer clinical trials' diversity problem

Why Novartis is changing the name of its research labs

Cassava Sciences’ Alzheimer’s clinical trials should be halted

entertainment

fashion

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Smaller biotechs seek to piggyback on weight loss drug boom

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A new House health package & hospitals’ new site

Sports medicine is finally prioritizing gender equality

AstraZeneca chief proposes a novel edit to the drug pricing bill

State Dept. review finds Biden bears some blame for Afghanistan failures

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Psychedelics group wrestles with new pharma identity

How AI can help patients find reliable information about doctors

leisure time

A new House health package & hospitals’ new site

Study on Amgen’s bispecific immunotherapy produces positive data

Merck, Daiichi strike cancer drug pact worth up to $22 billion

ALS advocates say criticism of new drugs misses bigger picture

Results on Novartis prostate cancer therapy could expand its use

STAT Readout Newsletter: Biotech news today

focus

entertainment

Wikipedia

Wikipedia